Axelrod J L, Klein R M, Bergen R L, Sheikh M Z
Am J Ophthalmol. 1985 Oct 15;100(4):570-5. doi: 10.1016/0002-9394(85)90683-x.
Staphylococcus epidermidis and S. aureus are the most common causes of bacterial endophthalmitis. A study of the penetration of selected antistaphylococcal antibiotics into human vitreous was undertaken in 58 patients. After 2-g intravenous doses of cephalothin, cefazolin, methicillin, oxacillin, or nafcillin were given to patients about to undergo vitreous surgery, mean vitreous levels for each antibiotic were as follows: cephalothin, 0.97 microgram/ml in diabetics and 0.69 microgram/ml in nondiabetics; cefazolin, 0.84 microgram/ml in diabetics and 1.6 microgram/ml in nondiabetics; methicillin, 2.56 micrograms/ml in diabetics and 2.64 micrograms/ml in nondiabetics; oxacillin, 0.62 microgram/ml in diabetics and 0.34 microgram/ml in nondiabetics; and nafcillin, 0.73 microgram/ml in diabetics and 0.75 microgram/ml in nondiabetics. Only cefazolin produced vitreous concentrations consistently above its minimum inhibitory concentration for 90% of S. epidermidis isolates. Staphylococcus aureus isolates were not similarly covered. There was a trend toward higher vitreous antibiotic concentrations in patients with proliferative vitreoretinopathy and rubeosis.
表皮葡萄球菌和金黄色葡萄球菌是细菌性眼内炎最常见的病因。对58例患者进行了一项关于选定抗葡萄球菌抗生素在人玻璃体中渗透情况的研究。在即将接受玻璃体手术的患者静脉注射2克头孢噻吩、头孢唑林、甲氧西林、苯唑西林或萘夫西林后,每种抗生素的平均玻璃体浓度如下:头孢噻吩,糖尿病患者中为0.97微克/毫升,非糖尿病患者中为0.69微克/毫升;头孢唑林,糖尿病患者中为0.84微克/毫升,非糖尿病患者中为1.6微克/毫升;甲氧西林,糖尿病患者中为2.56微克/毫升,非糖尿病患者中为2.64微克/毫升;苯唑西林,糖尿病患者中为0.62微克/毫升,非糖尿病患者中为0.34微克/毫升;萘夫西林,糖尿病患者中为0.73微克/毫升,非糖尿病患者中为0.75微克/毫升。只有头孢唑林产生的玻璃体浓度始终高于其对90%的表皮葡萄球菌分离株的最低抑菌浓度。金黄色葡萄球菌分离株未得到类似的覆盖。增殖性玻璃体视网膜病变和虹膜红变患者的玻璃体抗生素浓度有升高的趋势。